epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Farxiga
    dapagliflozin
  • remove modafinil
    generic
  • remove Steglatro
    ertugliflozin

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Farxiga (dapagliflozin) + Steglatro (ertugliflozin)

Avoid/Use Alternative


dapagliflozin + ertugliflozin

avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information